- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Top cancer drugs paid by Medicare Part B by sales price per dosage 2014
Top cancer drugs paid by Medicare Part B by sales price per dosage 2014
Leading Medicare Part B cancer drugs based on average sales price per dosage in 2014 (in U.S. dollars)
by Statista Research Department,
last edited
Mar 17, 2016
This statistic displays the leading Medicare Part B cancer drugs based on average sales price per dosage in 2014, in U.S. dollars. The average sales price for one dose (1 mg) of a Denosumab injection totaled 14.45 U.S. dollars. The size and demographic of medical professionals in oncology plays a significant role in the accessibility and quality of cancer care for patients in the United States.
Leading Medicare Part B cancer drugs based on average sales price per dosage in 2014 (in U.S. dollars)
Loading statistic...
| Name (dose) | Sales price per dosage in U.S. dollars |
|---|---|
| Pegfilgrastim injection* (6mg) | 3,387.93 |
| Aflibercept injection* (0.1mg) | 980.5 |
| Rituximab injection* (100mg) | 708.68 |
| Ranibizumab injection (0.1mg) | 396.43 |
| Trastuzumab injection* (10mg) | 82.49 |
| Infliximab injection (10mg) | 74.34 |
| Bevacizumab injection* (10mg) | 66.65 |
| Pemetrexed injection* (10mg) | 60.27 |
| Bortezomib injection* (0.1mg) | 46.08 |
| Denosumab injection* (1mg) | 14.45 |
| Name (dose) | Sales price per dosage in U.S. dollars |
|---|---|
| Pegfilgrastim injection* (6mg) | 3,387.93 |
| Aflibercept injection* (0.1mg) | 980.5 |
| Rituximab injection* (100mg) | 708.68 |
| Ranibizumab injection (0.1mg) | 396.43 |
| Trastuzumab injection* (10mg) | 82.49 |
| Infliximab injection (10mg) | 74.34 |
| Bevacizumab injection* (10mg) | 66.65 |
| Pemetrexed injection* (10mg) | 60.27 |
| Bortezomib injection* (0.1mg) | 46.08 |
| Denosumab injection* (1mg) | 14.45 |
© Statista 2019
About this statistic
Source: Moran Company
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Statista Research Department,
last edited
Mar 17, 2016
This statistic displays the leading Medicare Part B cancer drugs based on average sales price per dosage in 2014, in U.S. dollars. The average sales price for one dose (1 mg) of a Denosumab injection totaled 14.45 U.S. dollars. The size and demographic of medical professionals in oncology plays a significant role in the accessibility and quality of cancer care for patients in the United States.
- Source
- Moran Company
- Show further sources information
- Show publisher information
- Release date
- March 2016
- Region
- United States
- Survey time period
- 2014
- Supplementary notes
-
Values are for drugs delivered in the physician office and at home.
* Drugs used for treatment of patients with cancer. Pricing data reflects 4th quarter 2014 payment rates, which correspond to 2nd quarter 2014 manufacturer reports.
Source
- Source
- Moran Company
- Show further sources information
- Show publisher information
- Release date
- March 2016
More information
- Region
- United States
- Survey time period
- 2014
- Supplementary notes
-
Values are for drugs delivered in the physician office and at home.
* Drugs used for treatment of patients with cancer. Pricing data reflects 4th quarter 2014 payment rates, which correspond to 2nd quarter 2014 manufacturer reports.
Other statistics on the topic
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Cancer in Italy"
- Incidence
The most important statistics
- Estimated number of new cancer cases among males in Italy in 2018, by type of cancerItaly: new cancer cases among males 2018, by type of cancer
- Number of new cancer cases among females in Italy in 2018, by type of cancerItaly: new cancer cases among females 2018, by type of cancer
- Number of new cancer cases among males in Italy as of 2018, by regionItaly: number of new cancer cases among males 2018, by region
- Number of new cancer cases among females in Italy as of 2018, by regionItaly: number of new cancer cases among females 2018, by region
- The most frequently diagnosed cancers among males in Italy as of 2018*Italy: the most frequently diagnosed cancers among males 2018
- The most frequently diagnosed cancers among females in Italy as of 2018*Italy: the most frequently diagnosed cancers among females 2018
- Estimated number of cases of cancer from human papilloma virus (HPV) in Italy as of 2017, by genderItaly: estimated number of cancer cases caused by HPV 2017, by gender
- Prevalence rate of leukemia in Italy from 2010 to 2017 (per 100,000 population)Italy: prevalence of leukemia 2010-2017
- Screening
The most important statistics
- Share of females undergoing breast cancer screening from 2008 to 2017Italy: share of females undergoing breast cancer screening 2008-2017
- Share of women aged 50-69 years screened for breast cancer in Italy between 2014 and 2017, by regionItaly: share of women screened for breast cancer 2014-2017, by region
- Share of women undergoing cervical cancer screening in Italy from 2008 to 2017Italy: share of women undergoing cervical cancer screening 2008-2017
- Share of women aged 25-64 years screened for cervical cancer in Italy between 2014 and 2017, by region Italy: share of women screened for cervical cancer 2014-2017, by region
- Share of women who underwent a Pap test in Italy from 2009 to 2016, by age groupItaly: women who underwent Pap test 2009-2016, by age group
- Share of individuals aged 50-69 years screened for colorectal cancer in Italy between 2014 and 2017, by regionItaly: share of individuals screened for colorectal cancer 2014-2017, by region
- Mortality
The most important statistics
- Cancer mortality rate among males in Italy from 2006 to 2015 (per 10,000 inhabitants)Italy: cancer mortality rate among males 2006-2015
- Cancer mortality rate among females in Italy from 2006 to 2015 (per 10,000 inhabitants)Italy: cancer mortality rate among females 2006-2015
- Number of deaths from stomach cancer in Italy in 2015, by gender and geographic areaItaly: number of deaths from stomach cancer 2015, by gender and area
- Number of deaths from colorectal cancer in Italy in 2015, by gender and geographic areaItaly: number of deaths from colorectal cancer 2015, by gender and area
- Number of deaths from pancreatic cancer in Italy in 2015, by gender and geographic areaItaly: number of deaths from pancreatic cancer 2015, by gender and area
- Number of deaths from liver cancer* in Italy in 2015, by gender and geographic areaItaly: number of deaths from liver cancer 2015, by gender and area
- Number of deaths from trachea, bronchus and lung cancers in Italy in 2015, by gender and geographic areaItaly: number of deaths from lung cancer 2015, by gender and area
- Number of deaths from brain cancer in Italy in 2015, by gender and geographic areaItaly: number of deaths from brain cancer 2015, by gender and area
- Care and treatments
The most important statistics
- Public expenditure on cancer drugs in Italy from 2012 to 2015 (in million euros)Italy: public expenditure on cancer drugs 2012-2015
- Expenditure for oncology drugs in Italy in 2018, by category (in million euros)Expenditure for oncology drugs in Italy 2018, by category
- Distribution of expenditure on cancer drugs in Italy in 2018, by typeDistribution of expenditure on cancer drugs in Italy 2018, by type
- Expenditure on innovative cancer drugs in Italy in 2018, by region (in euros)Expenditure on innovative cancer drugs in Italy 2018, by region
- Level of consumption of cancer drugs in Italy from 2013 to 2017 (in DDD* per 1,000 inhabitants per day)Consumption of cancer drugs in Italy 2013-2018
- Trend of consumption of antineoplastic drugs in Italy from 2011 to 2018 (in DDD* per 1,000 inhabitants per day)Consumption of antineoplastic drugs in Italy 2011-2018
- Average waiting time to get an appointment for a colonoscopy in a public facility in Italy in selected years between 2014 and 2017Italy: waiting time for a colonoscopy in a public facility 2014-2017
- Has ever occurred to you to work below suitable qualitative criteria because of lack of budget?Italy: oncological surgeons experiencing budgetary restraints 2018
- Research and fundraising
The most important statistics
- Number of clinical trials authorized by the Italian Medicines Agency in Italy in 2017, by therapeutic area*Italy: number of clinical trials 2017, by therapeutic area
- Total amount allocated with cinque per mille to Italian Association for Cancer Research from 2013 to 2016 in Italy (in euros)Italy: charity funds allocated to Italian Association for Cancer Research 2013-2016
- Total amount allocated with cinque per mille to Istituto Europeo di Oncologia from 2013 to 2016 in Italy (in euros)Italy: cinque per mille allocated to Istituto Europeo di Oncologia 2013-2016
- Total amounts collected with fundraising activities by the Italian Association for Cancer Research from 2012 to 2018 (in million euros)Italy: amounts collected with fundraising by Italian Association for Cancer Research
- Funds raised by the Italian Association for Cancer Research from 2012 to 2018, by source (in million euros)Italy: funds raised by Italian Association for Cancer Research 2012-2018, by source
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Expensive cancer drugs by annual Medicare payments in the U.S. 2014
- Italy: oncologists' behavior when facing budgetary restraints 2018
- Italy: oncologists' behavior towards patients when facing budgetary restraints 2018
- Net price index for cancer products in developed markets 2014
- Concern over NHS provision of cancer drugs in the United Kingdom (UK) 2015, by age
- Rates of Medicare acceptance in select U.S. metropolitan areas by specialty 2013
- Medicare hospital inpatient charges by disease in the U.S. 2016
- Penetration of Medicare Advantage into Medicare 2004-2017
- Leading ten Medicare Advantage organizations by enrollment 2017
- Percentage of Medicare Advantage plans by plan type 2018
- Enrollment of Medicare Advantage by plan type 2011-2017
- Medicare Part D payer share of branded and generic drugs by therapy area 2015
- Medicare Advantage enrollment in top ten states in the U.S. 2017
- Growth in Medicare per capita spending compared to economic benchmarks 2011-2020
- Major chronic conditions in Medicare spending
- Worldwide revenue of cancer drugs
- Proportion of cancer drugs on the world pharmaceutical market
- Number of Medicare-certified ambulatory surgery centers by state 2016
Studies
- Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans: 2017 Year-En...
- Drug Use Among Seniors in Canada, 2016
- Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans: 2006 to 2015
- Trends in Retail Prices of Brand Name Prescription Drugs Widely Used by Older Americans: 2...
Statistics on "Cancer in Italy"
- Italy: new cancer cases among males 2018, by type of cancer
- Italy: new cancer cases among females 2018, by type of cancer
- Italy: number of new cancer cases among males 2018, by region
- Italy: number of new cancer cases among females 2018, by region
- Italy: the most frequently diagnosed cancers among males 2018
- Italy: the most frequently diagnosed cancers among females 2018
- Italy: estimated number of cancer cases caused by HPV 2017, by gender
- Italy: prevalence of leukemia 2010-2017
- Italy: number of people alive after cancer diagnosis 2015, by type
- Italy: share of females undergoing breast cancer screening 2008-2017
- Italy: share of women screened for breast cancer 2014-2017, by region
- Italy: share of women undergoing cervical cancer screening 2008-2017
- Italy: share of women screened for cervical cancer 2014-2017, by region
- Italy: women who underwent Pap test 2009-2016, by age group
- Italy: share of individuals screened for colorectal cancer 2014-2017, by region
- Italy: cancer mortality rate among males 2006-2015
- Italy: cancer mortality rate among females 2006-2015
- Italy: number of deaths from stomach cancer 2015, by gender and area
- Italy: number of deaths from colorectal cancer 2015, by gender and area
- Italy: number of deaths from pancreatic cancer 2015, by gender and area
- Italy: number of deaths from liver cancer 2015, by gender and area
- Italy: number of deaths from lung cancer 2015, by gender and area
- Italy: number of deaths from brain cancer 2015, by gender and area
- Italy: number of deaths from lymphatic cancer 2015, by gender and area
- Italy: number of deaths from bladder cancer 2015, by gender and area
- Italy: number of deaths from leukemia 2015, by gender and area
- Italy: breast cancer mortality rate 2015, by region
- Italy: uterine cancer mortality rate 2015, by region
- Italy: prostate cancer mortality rate 2015, by region
- Italy: public expenditure on cancer drugs 2012-2015
- Expenditure for oncology drugs in Italy 2018, by category
- Distribution of expenditure on cancer drugs in Italy 2018, by type
- Expenditure on innovative cancer drugs in Italy 2018, by region
- Consumption of cancer drugs in Italy 2013-2018
- Consumption of antineoplastic drugs in Italy 2011-2018
- Italy: waiting time for a colonoscopy in a public facility 2014-2017
- Italy: oncological surgeons experiencing budgetary restraints 2018
- Italy: oncologists' opinion about scarcity of resources to treat cancer patients 2018
- Italy: oncologists' opinion about equity of access to oncological treatments 2018
- Italy: oncological surgeons' opinion about scarcity of resources 2018
- Italy: oncological surgeons opinion about financial restraints 2018
- Italy: number of clinical trials 2017, by therapeutic area
- Italy: charity funds allocated to Italian Association for Cancer Research 2013-2016
- Italy: cinque per mille allocated to Istituto Europeo di Oncologia 2013-2016
- Italy: amounts collected with fundraising by Italian Association for Cancer Research
- Italy: funds raised by Italian Association for Cancer Research 2012-2018, by source
- Expensive cancer drugs by annual Medicare payments in the U.S. 2014
- Italy: oncologists' behavior when facing budgetary restraints 2018
- Italy: oncologists' behavior towards patients when facing budgetary restraints 2018
- Net price index for cancer products in developed markets 2014
- Concern over NHS provision of cancer drugs in the United Kingdom (UK) 2015, by age
- Rates of Medicare acceptance in select U.S. metropolitan areas by specialty 2013
- Medicare hospital inpatient charges by disease in the U.S. 2016
- Penetration of Medicare Advantage into Medicare 2004-2017
- Leading ten Medicare Advantage organizations by enrollment 2017
- Percentage of Medicare Advantage plans by plan type 2018
- Enrollment of Medicare Advantage by plan type 2011-2017
- Medicare Part D payer share of branded and generic drugs by therapy area 2015
- Medicare Advantage enrollment in top ten states in the U.S. 2017
- Growth in Medicare per capita spending compared to economic benchmarks 2011-2020
- Major chronic conditions in Medicare spending
- Worldwide revenue of cancer drugs
- Proportion of cancer drugs on the world pharmaceutical market
- Number of Medicare-certified ambulatory surgery centers by state 2016
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account
|
Instant Access
Premium Account
| ||
|---|---|---|---|
Our services
Click the question mark for further information | Free |
$49 per month*
| |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Yes, let me download!
...and make my research life easier.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.